BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting

27 February 2023, Zwingenberg (Germany) - BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry, had a strong start into the fiscal year with very satisfying revenue growth in both divisions. Cash on hand improved by € 2.4 million to € 10.8 million from last quarter which includes the disposal proceeds from L.A. Schmitt GmbH.